
Pharma Pulse 5/29/24: The Impact of Wearables in Clinical Research,Prospects for Comprehensive PBM Reform & more
The latest news for pharma industry insiders.
Jeremy Wyatt, CEO of ActiGraph, discusses how these devices are changing patient monitoring in clinical trials.
Paul Kelly, of Capitol Advocacy & Government Affairs, LLC , and a veteran Washington, D.C., lobbyist, sees some obstacles to the Senate passig a comprehensive PBM bill.
Move comes after firm became embroiled in a legal battle over a new voice assistant in its latest artificial-intelligence model.
Conceive, Evernow, FitOn, Nurx, Cove, and Nutrium Join as Founding Members to Support the Coalition’s Focus on Expanding Access to Women-Centered Healthcare Resources in the Workplace.
About the opportunities for #ai in #pharma and why #israelinnovation🇮🇱 is poised to play a role in Pharmaceutical Executive
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

